Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
Want to see ARDT full AI Analyst Report?
ARDT Stock Chart & Stats
$9.91
$0.02(0.12%)
At close: 4:00 PM EST
$9.91
$0.02(0.12%)
Day’s Range― - ―
52-Week Range$7.71 - $15.48
Previous CloseN/A
Volume15.92K
Average Volume (3M)573.34K
Market Cap
$1.28B
Enterprise Value$2.98B
Total Cash (Recent Filing)$609.69M
Total Debt (Recent Filing)$2.29B
Price to Earnings (P/E)9.4
Beta0.60
Next Earnings
Aug 19, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.95
Shares Outstanding143,350,040
10 Day Avg. Volume636,795
30 Day Avg. Volume573,343
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.74
Price to Sales (P/S)0.20
P/FCF Ratio4.81
Enterprise Value/Market Cap2.33
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit0.93
Enterprise Value/Ebitda5.89
Forecast
1Y Price Target
$12.36Price Target Upside24.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)1.12
Revenue Forecast (FY)$6.55B
Bulls Say, Bears Say
Bulls Say
Balance-sheet DeleveragingMaterial leverage reduction and ample liquidity materially lower financial risk and increase strategic optionality. With net leverage around 1.0x and sizable cash, Ardent can fund capex, ambulatory expansion, IMPACT investments or absorb reimbursement shocks without immediate refinancing pressure.
IMPACT Cost Program Driving MarginsA clearly defined, executing cost program producing measurable savings supports sustainably higher margins. Durable labor, supply and contract-labor improvements (eg. contract labor down >40%) indicate structural cost base optimization that can persist beyond cyclical volume swings.
Ambulatory And Digital ExpansionExpanding higher-margin ambulatory footprint and deploying AI-assisted virtual care are strategic moves to shift volumes to lower-cost sites and improve labor efficiency. These initiatives diversify revenue mix and support long-term margin and access improvements across the system.
Bears Say
Thin, Inconsistent ProfitabilityPersistently thin net margins and volatile ROE limit internal capital accumulation and increase sensitivity to reimbursement or cost shocks. Low profitability constrains ability to self-fund growth, heightens reliance on efficiency programs, and makes earnings vulnerable to adverse payer or seasonal trends.
Moderate Cash Conversion And Recent FCF SoftnessOnly moderate free cash flow conversion reduces financial flexibility for reinvestment, debt paydown or shareholder returns. Softening FCF and occasional negative quarterly cash flows amplify exposure to working-capital timing, reimbursement delays, and any capex ramp for growth projects.
Exchange/payer-mix And Revenue Recovery RiskStructural shifts toward higher patient cost-sharing and elevated denials threaten revenue throughput and collections. A multi-year risk exists that payer mix changes and underpayments will depress realized reimbursement and require sustained investment in denial-management and patient financial programs.
Ardent Health Partners, Inc. News
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $7.71 and its highest was $15.48 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.28B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 59 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.191 by $0.089.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.25.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 143,350,040 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.191. Following the earnings report the stock price went down -7.502%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.36 (24.69% Upside)
$12.36 (24.69% Upside)
Blogger Sentiment
Bullish
ARDT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 699.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $186.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.7%
Last 30 Days ▲ 8.0%
Last 30 Days ▲ 8.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.25%
12-Months-Change
Fundamentals
Return on Equity
9.08%
Trailing 12-Months
Asset Growth
6.95%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Operating a vast network of hospitals and clinics throughout the United States, Ardent Health Partners, LLC delivers a diverse array of healthcare services. Its portfolio notably includes acute care facilities, alongside specialized rehabilitation and surgical hospitals. This healthcare organization, founded in 2001, is headquartered in Brentwood, Tennessee, and operates under the ownership of EGI-AM Investments, L.L.C.
ARDT Company Deck
ARDT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: solid top-line growth (+7% revenue), strong adjusted EBITDA improvement (+26%, or +15% excluding a one-time investment gain), meaningful margin expansion (110 bps), demonstrable cost and labor discipline (contract labor down >40%, SW&B per AA improvements), and healthy liquidity and leverage metrics. Management acknowledged near-term volume headwinds from weather and lighter flu, exchange-related revenue pressure (~$35M estimated headwind), higher professional fees and medical malpractice premium increases, and ongoing denial-management work. On balance, the positive execution against the IMPACT program, margin gains, cash/liquidity strength, and disciplined growth initiatives outweigh the noted challenges.View all ARDT earnings summariesARDT Stock 12 Month Forecast
Average Price Target
$12.36
▲(24.69% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.69% Insiders
3.55% Mutual Funds
65.08% Other Institutional Investors
25.94% Public Companies and
Individual Investors